Director, Molecular & Cellular Immunology

Stylus Medicine; Cambridge (MA); On-site; USD 225,000 - 240,000; Full time

Job summary

Stylus Medicine, Cambridge, MA, seeks a Director of Molecular & Cellular Immunology to lead the immunology team and drive in vivo CART therapy programs. You will oversee in vitro workflows, strategize experimental designs, and advance the lead CART program toward development candidate nomination, collaborating with the SVP and broader team.

The role demands a PhD with 8+ years post-doc experience in immunology or related fields, a proven drug-discovery track record, and strong leadership in

Qualifications

• PhD in Molecular or Cellular Biology, Virology, Immunology or related field of study with deep immunology expertise.
• 8+ years of post-graduate experience with at least 5 years in drug discovery in pharma/biotech.
• Proven track record leading immunology or engineered immune cell therapy programs from discovery to IND or higher.
• Demonstrated expertise in immune-modulating design and test-optimize cycles for immune cargos.
• Experience with T cell engaging bispecific antibodies and antibody discovery is preferred.
• Experience managing and developing scientists as direct reports.
• Ability to excel in cross-functional collaborations and communicate complex data clearly.

Responsibilities

• Conceptualize in vivo T cell therapeutic product candidates using Stylus non-viral recombinase platform.
• Develop strategies and immune cell-based tests to generate preclinical data packages.
• Lead design and execution of experiments addressing lead program questions.
• Direct and mentor a team of scientists, ensuring progress to development candidate nomination.
• Collaborate with multidisciplinary teams and external partners to advance programs.
• Communicate results and strategies to stakeholders across the organization.
• Drive timely results with budget and milestone awareness; monitor latest literature for innovation.
• Manage external collaborations with academics, CROs, or corporate partners.

Skills

Leadership

Cross-functional collaboration

Critical thinking

Mentoring

Communication

Immunology expertise

Education

PhD in Molecular/Cellular Biology, Immunology or related field

Job description

Cambridge, Massachusetts, United States

About Stylus Medicine:

Stylus Medicine is developing transformative in vivo genetic medicines to unlock cures. Stylus combines engineered recombinases with non-viral delivery to specifically encode therapeutics. The company’s approach is versatile and modular, with potential therapeutic application across oncology, autoimmune, genetic diseases, and beyond.

About the Role:

Stylus Medicine is seeking an innovative, intellectually curious, and team-oriented Director, Molecular & Cellular Immunology to apply their deep immunology expertise and problem-solving abilities to collaboratively develop non-viral in vivo CART therapies. Reporting to the SVP, Immunology, this individual will lead the Molecular & Cellular Immunology team, with accountability for the execution of in vitro workflows in support of deepening our mechanistic understanding of the Stylus platform applied to immune cells, innovating within the platform, progressing the lead CART program to development candidate nomination, and preparing for advancement to clinic. This role is expected to serve as a close scientific thought partner with the SVP of Immunology, an effective collaborator with members of the broader scientific team, and a key driver in our mission to revolutionize the field of in vivo immune therapy.

Key Responsibilities & Accountabilities:

• Conceptualize in vivo T cell therapeutic product candidates applying Stylus non-viral recombinase engineering platform and build molecular designs to realize these product concepts
• Develop experimental strategies and immune cell-based testing systems to rigorously evaluate product candidate functional performance for development candidate nomination and preclinical data package generation
• Work closely with direct reports to focus experimental design and execution on solving key questions and scientific problems for the lead program and innovations, with hands-on lab contributions as necessary
• Lead, manage, mentor, and develop team of direct report scientists
• Apply immunology expertise in collaborative work with multi-disciplinary team members and external partners to execute programs consistent with overall strategy
• Communicate scientific concepts, strategies, status updates, and experimental results across the organization and to various high-level stakeholders
• Drive and deliver results with speed and rigor with timeline, milestone, and budgetary awareness
• Actively monitor the latest literature and technologies in the field to inspire or inform innovation and present Stylus data externally as appropriate
• May lead or manage collaborations with external partners ranging from academic, CROs and corporate entities to advance programs

Qualifications & Skills:

• PhD in Molecular or Cellular Biology, Virology, Immunology or related field of study with deep Immunology expertise
• 8+ years of post-graduate experience with a minimum of 5 years of drug discovery experience in the pharmaceutical and/or biotechnology industry
• Proven track-record of leading programs in immunology, immunotherapy or engineered immune cell therapy from early drug discovery to IND, with experience in CART
• A clear track record of accomplishment as demonstrated by clearly identifiable achievements such as patents, new initiatives, IND preparation,and publications
• Demonstrated expertise in immune-modulating molecule design and application of design-test-optimize cycles for functional evaluation of immune-relevant gene and cell therapy cargos
• Previous experience in the areas of T cell engaging bispecific antibodies and antibody discovery is preferred
• Experience managing and developing scientists as direct reports
• Ability to excel in internal and external cross-functional collaborations
• Ability to think critically, extract and synthesize simple principles from complex datasets and communicate them effectively

Pay Range: $225,000-$240,000

Voluntary Self-Identification

For government reporting purposes, we ask candidates to respond to the below self-identification survey.Completion of the form is entirely voluntary. Whatever your decision, it will not be considered in the hiringprocess or thereafter. Any information that you do provide will be recorded and maintained in aconfidential file.

As set forth in Stylus Medicine’s Equal Employment Opportunity policy,we do not discriminate on the basis of any protected group status under any applicable law.

If you believe you belong to any of the categories of protected veterans listed below, please indicate by making the appropriate selection.As a government contractor subject to the Vietnam Era Veterans Readjustment Assistance Act (VEVRAA), we request this information in order to measurethe effectiveness of the outreach and positive recruitment efforts we undertake pursuant to VEVRAA. Classification of protected categoriesis as follows:

A "disabled veteran" is one of the following: a veteran of the U.S. military, ground, naval or air service who is entitled to compensation (or who but for the receipt of military retired pay would be entitled to compensation) under laws administered by the Secretary of Veterans Affairs; or a person who was discharged or released from active duty because of a service-connected disability.

A "recently separated veteran" means any veteran during the three-year period beginning on the date of such veteran's discharge or release from active duty in the U.S. military, ground, naval, or air service.

An "active duty wartime or campaign badge veteran" means a veteran who served on active duty in the U.S. military, ground, naval or air service during a war, or in a campaign or expedition for which a campaign badge has been authorized under the laws administered by the Department of Defense.

An "Armed forces service medal veteran" means a veteran who, while serving on active duty in the U.S. military, ground, naval or air service, participated in a United States military operation for which an Armed Forces service medal was awarded pursuant to Executive Order 12985.